Biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer.

Sectors
Healthcare
Life Sciences
First Invested
2017
Public/PIPES
Company Status
NASDAQ: IMMU
Acquired by Gilead Sciences (NASDAQ: GILD)
Associated Team
Paul Walker